An aerosol-based drug treatment could drastically reduce the number of deaths among Covid-19 patients. It forms part of the body's natural fight against infection and the novel coronavirus suppresses its production in an attempt to evade an immune response. Delivering protein directly into the lungs of patients is designed to trigger a robust immune response to the virus, even in patients whose immune system is weakened by infection. He said the trial showed SNG001 was effective in "enhancing protection, accelerating recover and countering the impact of SARS-CoV-2 virus." Last month Britain-based researchers at the University of Oxford announced they had successfully reduced the risk of death among seriously ill patients by administering the steroid dexamethasone.

Source: Standard Digital July 20, 2020 21:00 UTC